Drug delivery systems for overcoming the bioavailability of curcumin: not only the nanoparticle matters

Nanomedicine (Lond). 2014 May;9(6):747-50. doi: 10.2217/nnm.14.21.

Authors

Jin-Rong Peng¹, Zhi-Yong Qian

Affiliation

¹ State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, PR China.

PMID: 24981645
DOI: 10.2217/nnm.14.21

No abstract available

Keywords: anticancer; bioavailability; drug delivery system; drug targeting; hydrogel–nanoparticle composites; nanomedicine; tissue engineering.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents / administration & dosage*
Antineoplastic Agents / pharmacokinetics
Biological Availability
Curcumin / administration & dosage*
Curcumin / pharmacokinetics
Drug Carriers / chemistry*
Drug Delivery Systems
Humans
Nanoparticles / chemistry*

Substances

Antineoplastic Agents
Drug Carriers
Curcumin